In a post-Metsera world, Structure Therapeutics could be the next big takeover candidate, analysts said Tuesday.

Biotechs are instead spending their time advancing the kind of smart science that will catch the eye of cash-rich ...

Monoclonal antibodies segment is set to dominate the industry, accounting for a market share of 34.5% in 2025. Based on source, microbial fermentation segment is projected to hold nearly one-fourth of ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

French biotech company Abivax's shares jumped by 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly might be interested in bidding for the business.

Nanobiotix (NASDAQ: NBTX) is a French biotechnology stock, and one that has soared 660% in 2025 as of Nov. 18. That's enough to draw investor attention, and to have many wondering if such torrid ...

The MarketWatch News Department was not involved in the creation of this content. The biotechnology market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing ...

The Global Pharmaceutical Bags Aseptic Filling Market is growing due to increasing demand for parenteral drugs, emphasis on ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

(MENAFN- GlobeNewsWire - Nasdaq) Burlingame, CA, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The Global Biotech Ingredients Market is estimated to be valued at USD 55.21 Bn in 2025 and is expected to reach USD ...